• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    N

    Nevill Hall Hospital,Aneurin Bevan University Health Board,National Health Service Wales

    EST. 1970
    388论文总数
    5,000引用总数

    Nevill Hall Hospital (Welsh: Ysbyty Nevill Hall) is a district general hospital in Abergavenny, north Monmouthshire, Wales. It is managed by the Aneurin Bevan University Health Board.

    论文量&引用量时间轴

    机构学者

    论文(388)

    年份
    起
    –
    止
    排序
    1Panhypopituitarism Associated with Ectopic Posterior Pituitary Presenting As Delayed Puberty in an Adolescent Male
    Me,Fiona Smeeton
    2026EUROPEAN JOURNAL OF ENDOCRINOLOGY(2026)
    引用
    AI阅读
    加入学术空间
    2Efficacy and Safety of Topical Delgocitinib for Chronic Hand Eczema:A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Rafaela de Moraes-Souza, Maria Júlia Pilau Bornia, Regina Chahine Chater, Francesco Piscazzi, Matheus Barros de Albuquerque,Yasmin Mesquita, Izadora Lapenda, Guillermo Servera-Negre,Natalia Hernández-Cano, Rubiana Sarto,Pedro Herranz-Pinto

    Chronic hand eczema (CHE) is associated with substantial functional impairment and reduced quality of life. Delgocitinib, a pan-Janus kinase (JAK) inhibitor, has emerged as a promising topical treatment for CHE. A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to assess the efficacy and safety of topical delgocitinib 20-30 mg/g compared with vehicle in patients with CHE. PubMed, Embase, Cochrane Library, ClinicalTrials.gov, EU CTR, and WHO ICTRP were searched up to 15 February 2026. The primary outcome was treatment success at week 16, defined as clear or almost clear skin with a ≥ 2-point improvement on the Investigator's or Physician's Global Assessment (IGA/PGA). Secondary outcomes included treatment success at weeks 4 and 8, changes in Hand Eczema Symptom Diary (HESD) itch and pain scores, and safety outcomes. Relative risks (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated using random-effects models. Three publications reporting four RCTs involving 1154 patients were included, with 752 receiving delgocitinib and 402 receiving vehicle. At week 16, treatment success was significantly higher with delgocitinib (RR 3.17; 95% CI 1.78-5.65; p < 0.01), corresponding to an absolute risk difference of 16.9% and a number needed to treat (NNT) of 6 (95% CI 3-16). Similar results at weeks 4 and 8. Delgocitinib also led to significantly greater improvements in HESD itch and pain scores. No significant differences were found in overall adverse events (AEs), treatment-related AEs, or serious AEs. Discontinuation due to AEs was lower in the delgocitinib group. Delgocitinib 20-30 mg/g demonstrated greater efficacy than vehicle and a favourable safety profile, supporting its use as a topical treatment for CHE.

    2026Experimental dermatology(2026)
    引用
    AI阅读
    加入学术空间
    3Enhancing Diagnostic Pathways for Bronchopulmonary Neuroendocrine Tumors: Assessment of the South Wales Neuroendocrine Tumor Service Transformation
    Arouba Imtiaz, Oliver Burbidge, Mat Jones, Robin Ghosal, Janardhan Navaratnam, Craig Dyer, Helen E Davies,Mohid S Khan

    ABSTRACT Background Bronchopulmonary neuroendocrine tumors (bpNETs) are uncommon lung neoplasms posing significant diagnostic and therapeutic challenges. This study evaluates the impact of the transformation of the South Wales Neuroendocrine Cancer Service on diagnostic and management outcomes for bpNETs. Methods We retrospectively analyzed data from patients with typical and atypical carcinoids (TC and AC) diagnosed before and after commissioned service transformation (September 2017). Data were collected from network cancer databases and clinical portals. Demographics, diagnostic pathway times, diagnostic tests, treatment modalities, and survival outcomes were analyzed. Results Following transformation, significant reductions were observed in median times from presentation to diagnosis (p = 0.009), symptom onset to diagnosis (p = 0.006), and presentation to treatment (p = 0.020). No other significant differences were noted between pre‐ and post‐transformation groups. Incidental diagnoses increased, especially in TCs (53%). Usage of CgA, HIAA, EBUS biopsies, and Gallium PET scans increased post‐transformation. Surgical treatments were common, but there was an increase in systemic therapy post‐transformation. Conclusion Implementation of a collaborative care model and NET service transformation led to significant improvements in pathway times. This is one of the few studies describing such improvements in NETs. While survival outcomes showed promising trends, further research is needed to assess the long‐term impact on patient outcomes.

    2026Thoracic cancer(2026)
    引用
    AI阅读
    加入学术空间
    4EP1051 - ECE_2866 - Panhypopituitarism Associated with Ectopic Posterior Pituitary Presenting As Delayed Puberty in an Adolescent Male
    Me, Fiona Smeeton

    Abstract Background Ectopic posterior pituitary (EPP) is a rare congenital malformation caused by abnormal migration of neurohypophyseal tissue during embryogenesis. It is commonly associated with varying degrees of hypopituitarism. Clinical presentation may be subtle, resulting in delayed diagnosis, particularly in adolescence. Case Presentation A 17-year-old male was referred for assessment of delayed puberty and chronic fatigue. He reported a complete lack of energy, muscle aches, back pain, reduced exercise tolerance, and inability to participate in sports. Examination revealed a prepubertal appearance with absent secondary sexual characteristics, puffy hands, and height below the 50th centile. Hormonal evaluation demonstrated panhypopituitarism. IGF-1 was profoundly low at 2 nmol/L. Gonadotropins were suppressed (LH 0.1 IU/L, FSH 0.4 IU/L) with testosterone <0.2 nmol/L. Thyroid function tests showed inappropriately normal TSH of 4.4 mIU/L with low free T4 of 7.9 pmol/L, consistent with secondary hypothyroidism. Random cortisol was 47 nmol/L, and a short Synacthen test confirmed secondary adrenal insufficiency. MRI of the pituitary revealed an ectopic posterior pituitary, identified as a 4-mm T1-hyperintense focus at the median eminence, with absence of the posterior pituitary bright spot in the sella. Bone age was significantly delayed at 12.6 years compared with a chronological age of 16.8 years. The patient was commenced on hormone replacement therapy including prednisolone, levothyroxine, and intramuscular testosterone (Sustanon 250 mg every four weeks), with planned follow-up at six months. Prednisone was chosen by the patient to simplify dosing and improve adherence. Conclusions This case illustrates a rare but important cause of delayed puberty and chronic fatigue in adolescence. Recognition of ectopic posterior pituitary and associated hypopituitarism is essential, as early diagnosis and timely hormone replacement can significantly improve growth, pubertal progression, and overall quality of life.

    2026European Journal of Endocrinology(2026)
    引用
    AI阅读
    加入学术空间
    5Streamlining the Severe Asthma Pathway: Reducing Waiting Times and Improving Access to Treatment in Wales
    Michael Pynn, Kasia Zalewska, Laura Wiffen, Kelly Holmes,James Calvert

    Waiting times for severe asthma care in Wales are long, with many patients not accessing biologic medications in a timely manner. This quality improvement project used the Kotter Model, aiming to improve the efficiency and reduce waiting times of the severe asthma service at Aneurin Bevan University Health Board. Areas for improvement were identified via a mapping exercise, with the impact of targeted changes assessed using the metric of patient waiting times. Areas for improvement included referral, triage, diagnosis, multidisciplinary team meeting access and discharge/follow-up care. After 12 months, targeted changes resulted in an 8-week reduction in waiting times between multidisciplinary team approval and biologic prescribing, with the number of patients discussed per month in these meetings increasing from five to 30. This demonstrates how targeted changes and holistic pathway evaluation can lead to substantial improvements in patient waiting times and service efficiencies, while enhancing access to diagnostics and treatments for severe asthma and, potentially, other therapy areas.

    2026British Journal of Healthcare Management(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 388 篇论文

    合作机构(100)

    Royal Gwent Hospital,Aneurin Bevan University Health Board,National Health Service Wales合作论文 31
    威尔士大学医院合作论文 26
    卡迪夫大学合作论文 16
    Royal Glamorgan Hospital合作论文 8
    Princess of Wales Hospital,Swansea Bay University Health Board合作论文 7
    Morriston Hospital,Swansea Bay University Health Board合作论文 7
    斯旺西大学合作论文 5
    兰多夫大学医院合作论文 5
    Ysbyty Gwynedd合作论文 5
    新加坡医院合作论文 5

    机构统计